Patent classifications
C
C12
C12N
2760/00
C12N2760/00011
C12N2760/18011
C12N2760/18511
C12N2760/18532
C12N2760/18532
Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
The invention provides in part methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one or more microbes that are pathogenic in the specific organ or tissue in which the cancer is situated.
Composition comprising NC886 for improving oncolytic virus activity or production
12398376
·
2025-08-26
·
·
The present invention relates to a composition for enhancing oncolytic virus activity which comprises nc886, and a composition for enhancing virus production which comprises the same.